US Patent Issued to Principia Biopharma on Oct. 6 for "Methods for treating drug and vaccine induced immune thrombocytopenia by administering specific compounds" (British, American Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,954, issued on Oct. 6, was assigned to Principia Biopharma Inc. (Morristown, N.J.).

"Methods for treating drug and vaccine induced immune thrombocytopenia by administering specific compounds" was invented by Christopher W. Smith (Coventry, Great Britain), Steve P. Watson (Droitwich, Great Britain), Phillip L.R. Nicolson (Birmingham, Great Britain) and Claire Langrish (Redwood City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for treating and/or preventing drug-induced thrombocytopenia (DITP) and vaccine-induced thrombosis and thrombocytopenia syndrome (VITT) with certain BTK inhibitors and/or pharmaceutically acceptable salts thereo...